Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/12833462

Cancer 2003 Jul 1 98 1 100-9

Download in:

View as

Triples

General Info

PMID
12833462